Trump Administration
Refine Search
Pharmaceutical
A federal judge in Rhode Island has issued a sweeping order preventing the Trump administration from cutting $11 billion in public health grants, a move that preserves critical funding for 23 states and the District of Columbia as legal proceedings continue. 19 May 2025
Pharmaceutical
In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi company has sought to curry favor with US President Donald Trump in an announcement on pharma manufacturing. 15 May 2025
Pharmaceutical
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed HHS budget for fiscal year 2026 to the Senate Health, Education, Labor, and Pensions (HELP) Committee. 15 May 2025
Pharmaceutical
US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the Department of Health and Human Services (HHS) and the biopharma industry, with the threat of a rule from the Centers for Medicare and Medicaid Services (CMS) to lower US drug prices if no deal is reached. 14 May 2025
Pharmaceutical
US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices, a move that initially rattled investors but left many analysts unconvinced about its impact. 13 May 2025
Pharmaceutical
US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market. 12 May 2025
Pharmaceutical
UK-based pharma major AstraZeneca has started construction on a new manufacturing site for small molecule drugs in Wuxi, a city in East China's Jiangsu province, underscoring its deepening investment in the country. 12 May 2025
Pharmaceutical
The UK government has announced a trade agreement with the USA. The UK-US Economic Prosperity Deal was agreed on Thursday May 8 with further details released on Friday May 9. 9 May 2025
Pharmaceutical
UK pharma major AstraZeneca has suffered a setback in its legal fight to block the US government's efforts to lower prescription drug prices, after a federal appeals court dismissed its challenge to Medicare’s negotiation powers. 9 May 2025
Pharmaceutical
As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical imports, Indian drug-maker stocks continue to take a hammering on the bourses. 8 May 2025
Pharmaceutical
Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on its Section 232 investigation of pharmaceuticals and pharmaceutical ingredients imported to the USA. 8 May 2025
Pharmaceutical
US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for prescription drugs in the USA. 7 May 2025
Pharmaceutical
In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in their domestic policy package that would tie Medicaid drug payments to the lowest prices paid in other wealthy countries, a White House official confirmed to Inside Health Policy. 5 May 2025
Pharmaceutical
The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by the USA, are putting years of medical progress in jeopardy. 2 May 2025
Pharmaceutical
A new report from Washington DC-based group No Patient Left Behind argues that foreign governments are underestimating the value of innovative medicines — a claim that adds fuel to the ongoing transatlantic debate on drug pricing and access. 2 May 2025
Pharmaceutical
The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying it will now require all future vaccines to undergo testing in placebo-controlled trials before being approved for use. 2 May 2025
Pharmaceutical
Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump issued an executive order establishing the Make America Healthy Again Commission. 1 May 2025
Pharmaceutical
AstraZeneca posted a 10% rise in first-quarter revenue to $13.6 billion, supported by strong sales of cancer drugs and biopharmaceuticals. Core earnings per share climbed 21% to $2.49, while reported EPS advanced 34% to $1.88. Pre-tax profits increased 21% year-on-year to $3.4 billion. 29 April 2025
Pharmaceutical
The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining childhood vaccination rates, published in JAMA. 28 April 2025
Pharmaceutical
The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to those paid in other developed nations, according to a Reuters report citing multiple industry sources. 23 April 2025
Pharmaceutical
US President Donald Trump several weeks ago threatened drug manufacturers with the prospect of an Executive Order mandating international reference price limitations, unless the manufacturers put forward proposals to significantly reduce drug prices by August 24. 15 September 2020
Pharmaceutical
The US Food and Drug Administration on Sunday issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19. 24 August 2020
Generics
US President Donald Trump on Thursday signed an Executive Order to increase American production of essential medical supplies and cut down the nation’s reliance on foreign producers of medicines. 7 August 2020
Pharmaceutical
US pharma trade group Pharmaceutical Research and Manufacturers of America (PhRMA) has responded to a report on drug pricing from industry analyst IQVIA. 7 August 2020
Generics
What was once a leading photography company, but which filed for bankruptcy protection in 2012, USA-based Eastman Kodak’s shares soared as much as 1,900% in two days, after the Wall Street Journal reported the company had won a $765M government loan under the Defense Production Act. 29 July 2020
Pharmaceutical
Early in the current White House administration, exceptionally strong rhetoric around drug pricing from US President Donald Trump rattled pharma markets, as investors feared new measures to control drug prices were imminent. 27 July 2020
Pharmaceutical
The right-wing Institute for Policy Innovation has criticized a reported proposal from US President Donald Trump to introduce international price benchmarking, part of a plan to control drug prices in the country. 24 July 2020
Biotechnology
As Gilead Sciences revealed the price of remdesivir, its potential antiviral treatment for COVID-19, the US government announced that it has got its hands on another huge batch of the drug. 30 June 2020
Biotechnology
Shares in US biotech Vaxart were gaining further on Monday following Friday’s 28% leap. 29 June 2020
Pharmaceutical
The US National Institutes of Health (NIH) and Swiss pharma giant Novartis have both stopped trials of hydroxychloroquine in COVID-19. 22 June 2020
Pharmaceutical
A legal challenge from healthcare professionals in the USA will seek to end “arbitrary interference” from the US regulator over the use of hydroxychloroquine (HCQ). 3 June 2020
Generics
The US government has awarded $354 million to a start-up, Phlow Corporation, to boost local production of drugs at risk of shortage, including medicines to treat COVID-19. 20 May 2020
Pharmaceutical
On Friday, US President Donald Trump announced the addition of two of the most highly respected and skilled professionals to the White House new initiative, dubbed Operation Warp Speed, the objective of which is to finish developing and then to manufacture and distribute a proven coronavirus vaccine as fast as possible. 16 May 2020
Pharmaceutical
The US House of Representatives and Senate on Wednesday and Thursday passed an $8.3 billion emergency funding package, which dwarfs the $2.5 billion request by the White House, and it was signed off by President Donald Trump on Friday morning. 6 March 2020
Pharmaceutical
Where previous exchanges with big pharma bosses have generally seen US President Donald Trump attempt to exert pressure on companies on pricing, Tuesday’s meeting saw him adopting a different tone. 4 March 2020
Pharmaceutical
As the Office of the US Trade Representative (USTR) prepares its annual “Special 301 Report,” the US pharmaceutical industry has submitted comments calling for an end to market access barriers globally. 10 February 2020
Pharmaceutical
In US President Donald Trump’s State of the Union address on Tuesday, he again called for further bipartisan legislation to lower drug prices. 5 February 2020
Pharmaceutical
Impeachment aside, there was some other news surrounding Donald Trump and his Administration on Wednesday. 19 December 2019
Pharmaceutical
The US House of Representatives has passed a bill brought forward by Speaker Nancy Pelosi that would allow Medicare to negotiate lower prices on as many as 250 drugs and apply those discounts to private health plans. 13 December 2019
Pharmaceutical
House Democrats announced on Monday they have reached a deal with the White House on the trade agreement with Canada and Mexico, bringing President Donald Trump closer to fulfilling a major legislative accomplishment, a revamp of the old NAFTA that Mr Trump scrapped, and a fulfillment of a key campaign promise by the president, reported CBS News and other media. 11 December 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Neurocrine develops and discovers treatments for neurological and endocrine-related diseases and disorders.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze